DIAGNOSIS: Novel molecular signatures for adrenocortical carcinoma

    loading  Checking for direct PDF access through Ovid


The advent of high-throughput molecular analysis has appreciably improved the diagnostic and prognostic workup of several types of cancer. A French study now offers hope that benign and malignant adrenocortical tumors can be distinguished on the basis of distinct differences in their gene-expression profiles.

Related Topics

    loading  Loading Related Articles